EurekAlert!

SOPHiA GENETICS announces poster presentations at ESMO 2024

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and ...

Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces it will share data demonstrating the utility of Myriad’s Precise MRD™ (molecular ...
Nasdaq

Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ...

WATERTOWN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ...
Labroots

Genetics Week Virtual Event Series 2023 (copy)

Labroots is excited to announce our 11th Annual Event in the Genetics Week Virtual Event Series held on May 16-18, 2023! Genetics Week Virtual Event Series 2023 will offer a multi-day content-rich ...
Labroots

Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2027

Labroots is excited to announce our 15th Annual Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2027 held on May 12th, 2027! The Precision Medicine: Genomics, ...